Cargando…
Nonalcoholic Fatty Liver Disease after Liver Transplant
Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in the world. The rising prevalence of nonalcoholic steatohepatitis (NASH) has led to a 170% increase in NASH cirrhosis as the listing indication for liver transplantation from 2004 to 2013. As of 2018...
Autores principales: | Shetty, Akshay, Giron, Fanny, Divatia, Mukul K., Ahmad, Muhammad I., Kodali, Sudha, Victor, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237139/ https://www.ncbi.nlm.nih.gov/pubmed/34221929 http://dx.doi.org/10.14218/JCTH.2020.00072 |
Ejemplares similares
-
Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges
por: Ahmad, Muhammad Imran, et al.
Publicado: (2022) -
Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation
por: Satapathy, Sanjaya K., et al.
Publicado: (2021) -
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2018) -
Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018) -
Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)